510(k) K150617
K150617 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas HSV 1 and 2 Test". The FDA issued a decision of Substantially Equivalent on Jun 1, 2015. The device falls under product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay), a Class II device regulated under 21 CFR 866.3305. Roche Molecular Systems, Inc. has 54 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 1, 2015
- Date Received
- Mar 10, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Herpes Simplex Virus Nucleic Acid Amplification Assay
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type
- 510(k)
A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.
Need the full FDA record for Roche Molecular Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.